What's new

Human medicines European public assessment report (EPAR): Aprovel, irbesartan, Date of authorisation: 26/08/1997, Revision: 50, Status: Authorised

Human medicines European public assessment report (EPAR): Aprovel, irbesartan, Date of authorisation: 26/08/1997, Revision: 50, Status: Authorised

Feb 11, 2025 - 16:26
 0
Human medicines European public assessment report (EPAR): Aprovel, irbesartan, Date of authorisation: 26/08/1997, Revision: 50, Status: Authorised
Human medicines European public assessment report (EPAR): Aprovel, irbesartan, Date of authorisation: 26/08/1997, Revision: 50, Status: Authorised
Read More

Tags:

Previous Article

Executive Steering Group on Shortages and Safety of Medicinal Products

Next Article

From new brands to innovation capabilities: Carlsberg’s expansion into soft drinks

Related Posts

Orphan designation: Autologous CD34+ cells transduced with a lentiviral vector containing the human RAG1 gene Treatment of recombination-activating gene 1 deficient severe combined immunodeficiency, 26/03/2014 Positive

Orphan designation: Autologous CD34+ cells transduced w...

Feb 20, 2025  0

EMEA-003497-PIP01-23

EMEA-003497-PIP01-23

Feb 13, 2025  0

Human medicines European public assessment report (EPAR): Bortezomib Fresenius Kabi, bortezomib, Date of authorisation: 14/11/2019, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 13, 2025  0